Fibrinogen-to-Albumin Ratio in Familial Mediterranean Fever: Association with Subclinical Inflammation

Abstract Background Familial Mediterranean fever (FMF) is the most seen monogenic periodic fever syndrome characterised by bouts of fever and serositis. It is known that subclinical inflammation (SI) can persist in the symptom-free period and lead to amyloidosis even under colchicine treatment. This study aimed to evaluate the role of the fibrinogen-to-albumin ratio (FAR) in FMF and its correlation with SI. Material and Methods A total of 112 patients with FMF and 78 controls were enrolled in this retrospective study. Demographic, laboratory and genetic data were obtained from the hospital records. Results The FAR values of the FMF cases were significantly higher than the control group (p<0.001). In the FMF group, the patients with SI had higher FAR values than those without SI (p<0.001). FAR was positively correlated with SI (r=0.413, p<0.001). The receiver operating characteristic curve analysis showed that FAR had a higher area under the curve value than albumin and fibrinogen. Conclusion Detecting SI in patients with FMF is crucial in preventing amyloidosis, the most devastating complication of FMF. FAR is a simple, inexpensive, easily obtained indicator which can be used for reflecting SI in FMF. Zusammenfassung Hintergrund Familiäres Mittelmeerfieber (FMF) ist das am häufigsten auftretende monogene periodische Fiebersyndrom, das durch Fieberschübe und Serositis gekennzeichnet wird. Die subklinische Entzündung (SI) kann bekanntlich auch in der symptomfreien Phase fortbestehen und zu Amyloidose führen, selbst unter Behandlung mit Colchicin. Ziel dieser Studie ist es, die Beziehung zwischen Fibrinogen und Albumin (AFR) bei FMF und deren Korrelation mit SI zu untersuchen. Material und Methoden Insgesamt wurden für diese retrospektive Studie 112 Patienten mit FMF und 78 Kontrollpatienten eingeschlossen. Die demographischen, labortechnischen und genetischen Daten wurden aus den Krankenhausunterlagen entnommen. Ergebnisse Die Werte von AFR bei Patienten mit FMF waren signifikant höher als die der Kontrollgruppe (<0,001). Patienten mit FMF mit SI zeigten höhere AFR-Werte als FMF-Patienten ohne SI (<0,001). AFR korrelierte positiv mit SI (r=0,413, p<0,001). Die Analyse der ROC-Kurve (Receiver Operating Characteristic) zeigte, dass AFR einen höheren Wert der Fläche unter der Kurve (AUC) hatte als Albumin und Fibrinogen. Diskussion Die Erkennung von SI bei FMF-Patienten ist entscheidend für die Vermeidung von Amyloidose, der schlimmsten Komplikation von FMF. AFR ist ein einfacher, kostengünstiger, leicht durchzuführender Indikator, der in FMF zur Spiegelung von SI verwendet werden kann.

[1]  Binbin Cui,et al.  Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer , 2021, Cancer management and research.

[2]  G. Yan,et al.  Relation of Fibrinogen-to-Albumin Ratio to Severity of Coronary Artery Disease and Long-Term Prognosis in Patients with Non-ST Elevation Acute Coronary Syndrome , 2020, BioMed research international.

[3]  H. Marzouk,et al.  Red Cell Distribution Width (RDW) as a marker of Subclinical Inflammation in Children with Familial Mediterranean Fever. , 2020, Current rheumatology reviews.

[4]  Zhengping Huang,et al.  The role of fibrinogen to albumin ratio in ankylosing spondylitis: Correlation with disease activity. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[5]  R. Cimaz,et al.  Periodic fever syndromes and the autoinflammatory diseases (AIDs) , 2019, Journal of translational autoimmunity.

[6]  I. Mitroulis,et al.  Autoinflammation: Lessons from the study of familial Mediterranean fever. , 2019, Journal of autoimmunity.

[7]  B. Goker,et al.  Chronic inflammation in adult familial Mediterranean fever patients: underlying causes and association with amyloidosis , 2019, Scandinavian journal of rheumatology.

[8]  J. Luyendyk,et al.  The multifaceted role of fibrinogen in tissue injury and inflammation. , 2019, Blood.

[9]  H. Ozdogan,et al.  Familial Mediterranean Fever. , 2019, Presse medicale.

[10]  Alaaddin Yorulmaz,et al.  Evaluation of hematological parameters in children with FMF , 2018, Clinical rheumatology.

[11]  Q. Ou,et al.  Correlation between albumin to fibrinogen ratio, C-reactive protein to albumin ratio and Th17 cells in patients with rheumatoid arthritis. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[12]  J. Braun,et al.  Evidenzbasierte Therapieempfehlungen für das familiäre Mittelmeerfieber , 2019, Zeitschrift für Rheumatologie.

[13]  D. Foell,et al.  The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases , 2018, Molecular and Cellular Pediatrics.

[14]  K. Mao,et al.  A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma , 2018, Journal of immunology research.

[15]  P. Brož,et al.  Function and mechanism of the pyrin inflammasome , 2018, European journal of immunology.

[16]  M. Otagiri,et al.  Clinical Implications Associated With the Posttranslational Modification-Induced Functional Impairment of Albumin in Oxidative Stress-Related Diseases. , 2017, Journal of pharmaceutical sciences.

[17]  N. Çakar,et al.  Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients , 2017, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[18]  Y. Yilmaz,et al.  Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study , 2016, Clinical Rheumatology.

[19]  D. Kastner,et al.  EULAR recommendations for the management of familial Mediterranean fever , 2016, Annals of the rheumatic diseases.

[20]  D. Foell,et al.  Increased serum concentrations of neutrophil-derived protein S100A12 in heterozygous carriers of MEFV mutations. , 2015, Clinical and experimental rheumatology.

[21]  D. Karabel,et al.  Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever , 2015, Italian Journal of Pediatrics.

[22]  E. Bora,et al.  Risk factors for subclinical inflammation in children with Familial Mediterranean fever , 2015, Rheumatology International.

[23]  E. Sönmezgöz,et al.  Simple Markers for Subclinical Inflammation in Patients with Familial Mediterranean Fever , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[24]  S. Moiseev,et al.  Predictors of AA amyloidosis in familial Mediterranean fever , 2015, Rheumatology International.

[25]  M. Uysal,et al.  As a New Inflammatory Marker for Familial Mediterranean Fever: Neutrophil-to-Lymphocyte Ratio , 2013, Inflammation.

[26]  S. Kelekçi,et al.  Comparison of acute phase response during attack and attack-free period in children with Familial Mediterranean Fever , 2013 .

[27]  I. Ben-Zvi,et al.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy , 2011, Nature Reviews Rheumatology.

[28]  D. Booth,et al.  Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. , 2006, Rheumatology.

[29]  A. Bakkaloğlu Familial Mediterranean fever , 2003, Pediatric Nephrology.

[30]  S. Akıncı,et al.  Serum sIL-2r, IL-6, IL-10 and TNF-α level in familial Mediterranean fever patients , 2003, Clinical Rheumatology.

[31]  S. Akıncı,et al.  Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. , 2003, Clinical rheumatology.

[32]  H. Yazici,et al.  Acute phase response in familial Mediterranean fever , 2002, Annals of the rheumatic diseases.

[33]  D. Zemer,et al.  Activation of the cytokine network in familial Mediterranean fever. , 1999, The Journal of rheumatology.

[34]  M. Ehrenfeld,et al.  Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. , 1999, American journal of medical genetics.

[35]  E. Ben-Chetrit,et al.  Familial Mediterranean fever , 1998, The Lancet.

[36]  M. Pras,et al.  Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. , 1998, American journal of medical genetics.

[37]  E. Sohar,et al.  FAMILIAL MEDITERRANEAN FEVER , 1959, Definitions.